ClinicalTrials.gov
ClinicalTrials.gov Menu

ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00662948
Recruitment Status : Suspended (No inclusion)
First Posted : April 21, 2008
Last Update Posted : June 13, 2018
Sponsor:
Collaborators:
GELCAB
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Information provided by (Responsible Party):
PETHEMA Foundation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Actual Primary Completion Date : October 2014
  Study Completion Date : No date given